Image Credit: Unsplash
Mounjaro (Tirzepatide) is a new FDA-approved medication for managing type 2 diabetes. Here are some key facts about this breakthrough drug.
Image Credit: Unsplash
It targets two hormone receptors—GIP and GLP-1—to control blood sugar effectively.
Image Credit: Unsplash
Many users experience significant weight loss as a secondary effect.
Image Credit: Unsplash
It helps the body use insulin more efficiently, lowering blood sugar levels.
Image Credit: Unsplash
Mounjaro was approved in 2022 as a treatment for for type 2 diabetes management.
Image Credit: Unsplash
It is administered through a simple weekly injection.
Image Credit: Unsplash
Studies suggest it may reduce the risk of heart disease in diabetics.
Image Credit: Unsplash
Possible side effects include nausea, vomiting, and digestive discomfort.
Image Credit: Unsplash
People with a history of thyroid cancer or pancreatitis should avoid it.
Image Credit: Unsplash
Image Credit: Unsplash
For More Stories
like this check out: